Ekso Bionics (NASDAQ:EKSO – Get Free Report) issued its quarterly earnings results on Monday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.02), Yahoo Finance reports. Ekso Bionics had a negative return on equity of 92.08% and a negative net margin of 68.41%. The firm had revenue of $4.13 million during the quarter, compared to analyst estimates of $6.00 million. During the same period in the prior year, the firm earned ($0.24) earnings per share.
Ekso Bionics Price Performance
NASDAQ:EKSO opened at $0.90 on Tuesday. The stock has a 50 day moving average price of $1.11 and a 200 day moving average price of $1.15. The stock has a market cap of $16.36 million, a PE ratio of -1.16 and a beta of 1.45. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.77 and a current ratio of 2.42. Ekso Bionics has a one year low of $0.83 and a one year high of $3.13.
Wall Street Analyst Weigh In
A number of brokerages have weighed in on EKSO. StockNews.com began coverage on Ekso Bionics in a report on Saturday. They issued a “hold” rating on the stock. HC Wainwright decreased their price target on shares of Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday.
About Ekso Bionics
Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Featured Stories
- Five stocks we like better than Ekso Bionics
- How is Compound Interest Calculated?
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- 3 Stocks Reporting Kitchen Sink Quarters to Usher in a Turnaround
Receive News & Ratings for Ekso Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics and related companies with MarketBeat.com's FREE daily email newsletter.